| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |